nodes	percent_of_prediction	percent_of_DWPC	metapath
Linezolid—MAOB—alcohol dependence	0.438	0.588	CbGaD
Linezolid—MAOA—alcohol dependence	0.307	0.412	CbGaD
Linezolid—MAOA—Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB—MAOB—alcohol dependence	0.0111	0.109	CbGpPWpGaD
Linezolid—MAOB—Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB—MAOA—alcohol dependence	0.00992	0.0974	CbGpPWpGaD
Linezolid—MAOA—Clearance of seratonin—ALDH2—alcohol dependence	0.00947	0.0929	CbGpPWpGaD
Linezolid—Increased thirst—Naltrexone—alcohol dependence	0.00917	0.0793	CcSEcCtD
Linezolid—MAOA—locus ceruleus—alcohol dependence	0.00863	0.232	CbGeAlD
Linezolid—MAOA—Amine Oxidase reactions—MAOB—alcohol dependence	0.0064	0.0628	CbGpPWpGaD
Linezolid—MAOB—Amine Oxidase reactions—MAOA—alcohol dependence	0.0057	0.056	CbGpPWpGaD
Linezolid—MAOA—Clearance of dopamine—SLC6A3—alcohol dependence	0.00533	0.0523	CbGpPWpGaD
Linezolid—MAOB—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00407	0.04	CbGpPWpGaD
Linezolid—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—ALDH2—alcohol dependence	0.00312	0.0307	CbGpPWpGaD
Linezolid—MAOB—nerve—alcohol dependence	0.00302	0.0814	CbGeAlD
Linezolid—MAOA—nerve—alcohol dependence	0.00258	0.0695	CbGeAlD
Linezolid—MAOA—Dopamine metabolism—MAOB—alcohol dependence	0.00249	0.0244	CbGpPWpGaD
Linezolid—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—alcohol dependence	0.00243	0.0239	CbGpPWpGaD
Linezolid—MAOB—Dopamine metabolism—MAOA—alcohol dependence	0.00222	0.0218	CbGpPWpGaD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00217	0.0213	CbGpPWpGaD
Linezolid—MAOA—Serotonin Transporter Activity—SLC6A4—alcohol dependence	0.00212	0.0208	CbGpPWpGaD
Linezolid—Lactic dehydrogenase activity increased—Acamprosate—alcohol dependence	0.00199	0.0172	CcSEcCtD
Linezolid—Neuropathy—Disulfiram—alcohol dependence	0.00194	0.0168	CcSEcCtD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.0018	0.0177	CbGpPWpGaD
Linezolid—Blood lactate dehydrogenase increased—Acamprosate—alcohol dependence	0.00175	0.0151	CcSEcCtD
Linezolid—Serotonin syndrome—Citalopram—alcohol dependence	0.00174	0.0151	CcSEcCtD
Linezolid—Loose stools—Naltrexone—alcohol dependence	0.00174	0.015	CcSEcCtD
Linezolid—Platelet count decreased—Naltrexone—alcohol dependence	0.00162	0.014	CcSEcCtD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00153	0.015	CbGpPWpGaD
Linezolid—Fungal skin infection—Citalopram—alcohol dependence	0.00146	0.0126	CcSEcCtD
Linezolid—Abdominal cramps—Naltrexone—alcohol dependence	0.00143	0.0123	CcSEcCtD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00136	0.0134	CbGpPWpGaD
Linezolid—MAOB—Alpha-synuclein signaling—SLC6A3—alcohol dependence	0.00131	0.0129	CbGpPWpGaD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.0013	0.0128	CbGpPWpGaD
Linezolid—MAOB—brainstem—alcohol dependence	0.0013	0.0349	CbGeAlD
Linezolid—Trauma—Citalopram—alcohol dependence	0.00128	0.0111	CcSEcCtD
Linezolid—Tongue discolouration—Citalopram—alcohol dependence	0.00126	0.0109	CcSEcCtD
Linezolid—MAOB—forebrain—alcohol dependence	0.00125	0.0337	CbGeAlD
Linezolid—MAOB—Tryptophan metabolism—ALDH2—alcohol dependence	0.00123	0.0121	CbGpPWpGaD
Linezolid—Transient ischaemic attack—Citalopram—alcohol dependence	0.00121	0.0104	CcSEcCtD
Linezolid—Vaginal moniliasis—Citalopram—alcohol dependence	0.00121	0.0104	CcSEcCtD
Linezolid—MAOB—adrenal cortex—alcohol dependence	0.00116	0.0313	CbGeAlD
Linezolid—Vulvovaginal candidiasis—Citalopram—alcohol dependence	0.00116	0.01	CcSEcCtD
Linezolid—MAOB—Biological oxidations—ADH6—alcohol dependence	0.00116	0.0113	CbGpPWpGaD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00114	0.0112	CbGpPWpGaD
Linezolid—Neuropathy peripheral—Disulfiram—alcohol dependence	0.00113	0.00979	CcSEcCtD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00113	0.0111	CbGpPWpGaD
Linezolid—Vulvovaginal mycotic infection—Citalopram—alcohol dependence	0.00112	0.00964	CcSEcCtD
Linezolid—MAOA—brainstem—alcohol dependence	0.00111	0.0298	CbGeAlD
Linezolid—MAOA—forebrain—alcohol dependence	0.00107	0.0288	CbGeAlD
Linezolid—MAOB—cardiovascular system—alcohol dependence	0.00106	0.0285	CbGeAlD
Linezolid—Hypoaesthesia—Disulfiram—alcohol dependence	0.00103	0.00892	CcSEcCtD
Linezolid—Platelet count decreased—Citalopram—alcohol dependence	0.00103	0.00886	CcSEcCtD
Linezolid—Vaginal inflammation—Acamprosate—alcohol dependence	0.00102	0.00879	CcSEcCtD
Linezolid—MAOA—adrenal cortex—alcohol dependence	0.00099	0.0267	CbGeAlD
Linezolid—MAOB—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000982	0.00964	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000962	0.00944	CbGpPWpGaD
Linezolid—Vaginal infection—Acamprosate—alcohol dependence	0.00096	0.0083	CcSEcCtD
Linezolid—MAOB—Biological oxidations—ADH1A—alcohol dependence	0.000957	0.0094	CbGpPWpGaD
Linezolid—Urine output increased—Acamprosate—alcohol dependence	0.00092	0.00795	CcSEcCtD
Linezolid—Ecchymosis—Acamprosate—alcohol dependence	0.00092	0.00795	CcSEcCtD
Linezolid—MAOA—cardiovascular system—alcohol dependence	0.000903	0.0243	CbGeAlD
Linezolid—Abdominal cramps—Citalopram—alcohol dependence	0.000903	0.00781	CcSEcCtD
Linezolid—MAOB—digestive system—alcohol dependence	0.000879	0.0237	CbGeAlD
Linezolid—MAOA—pancreas—alcohol dependence	0.000878	0.0237	CbGeAlD
Linezolid—Phlebitis—Acamprosate—alcohol dependence	0.000857	0.00741	CcSEcCtD
Linezolid—Thrombophlebitis—Acamprosate—alcohol dependence	0.000853	0.00737	CcSEcCtD
Linezolid—Polyuria—Acamprosate—alcohol dependence	0.000841	0.00727	CcSEcCtD
Linezolid—MAOB—blood—alcohol dependence	0.000837	0.0226	CbGeAlD
Linezolid—MAOB—midbrain—alcohol dependence	0.000827	0.0223	CbGeAlD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000818	0.00803	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—ADH4—alcohol dependence	0.000814	0.00799	CbGpPWpGaD
Linezolid—Phlebitis—Naltrexone—alcohol dependence	0.000811	0.00701	CcSEcCtD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000805	0.0079	CbGpPWpGaD
Linezolid—Injury—Acamprosate—alcohol dependence	0.000803	0.00694	CcSEcCtD
Linezolid—Fungal infection—Citalopram—alcohol dependence	0.00079	0.00683	CcSEcCtD
Linezolid—Disorientation—Naltrexone—alcohol dependence	0.000781	0.00675	CcSEcCtD
Linezolid—Thirst—Acamprosate—alcohol dependence	0.000776	0.00671	CcSEcCtD
Linezolid—Cardiac failure congestive—Naltrexone—alcohol dependence	0.00077	0.00666	CcSEcCtD
Linezolid—MAOA—digestive system—alcohol dependence	0.00075	0.0202	CbGeAlD
Linezolid—Hyponatraemia—Acamprosate—alcohol dependence	0.000741	0.00641	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Acamprosate—alcohol dependence	0.000738	0.00638	CcSEcCtD
Linezolid—Thirst—Naltrexone—alcohol dependence	0.000734	0.00635	CcSEcCtD
Linezolid—MAOB—endocrine gland—alcohol dependence	0.000726	0.0196	CbGeAlD
Linezolid—MAOA—Biological oxidations—ADH6—alcohol dependence	0.000725	0.00712	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000717	0.00704	CbGpPWpGaD
Linezolid—MAOA—blood—alcohol dependence	0.000714	0.0192	CbGeAlD
Linezolid—MAOA—midbrain—alcohol dependence	0.000705	0.019	CbGeAlD
Linezolid—Contusion—Citalopram—alcohol dependence	0.000699	0.00604	CcSEcCtD
Linezolid—Gastrointestinal haemorrhage—Naltrexone—alcohol dependence	0.000699	0.00604	CcSEcCtD
Linezolid—MAOB—testis—alcohol dependence	0.000693	0.0187	CbGeAlD
Linezolid—MAOB—Biological oxidations—ADH7—alcohol dependence	0.000692	0.00679	CbGpPWpGaD
Linezolid—Liver function test abnormal—Acamprosate—alcohol dependence	0.000682	0.00589	CcSEcCtD
Linezolid—MAOB—nervous system—alcohol dependence	0.00068	0.0183	CbGeAlD
Linezolid—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.000665	0.00575	CcSEcCtD
Linezolid—MAOB—Biological oxidations—GGT2—alcohol dependence	0.000664	0.00651	CbGpPWpGaD
Linezolid—Glossitis—Citalopram—alcohol dependence	0.000662	0.00572	CcSEcCtD
Linezolid—Paraesthesia—Disulfiram—alcohol dependence	0.000661	0.00572	CcSEcCtD
Linezolid—Drug interaction—Citalopram—alcohol dependence	0.000657	0.00568	CcSEcCtD
Linezolid—Somnolence—Disulfiram—alcohol dependence	0.000655	0.00566	CcSEcCtD
Linezolid—MAOB—liver—alcohol dependence	0.000655	0.0176	CbGeAlD
Linezolid—MAOB—central nervous system—alcohol dependence	0.000654	0.0176	CbGeAlD
Linezolid—Gastritis—Acamprosate—alcohol dependence	0.000653	0.00565	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.000651	0.00563	CcSEcCtD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000644	0.00632	CbGpPWpGaD
Linezolid—MAOB—cerebellum—alcohol dependence	0.00064	0.0172	CbGeAlD
Linezolid—Fatigue—Disulfiram—alcohol dependence	0.000635	0.00549	CcSEcCtD
Linezolid—Eosinophilia—Acamprosate—alcohol dependence	0.000632	0.00546	CcSEcCtD
Linezolid—Pain—Disulfiram—alcohol dependence	0.00063	0.00545	CcSEcCtD
Linezolid—Cramp muscle—Naltrexone—alcohol dependence	0.000629	0.00544	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.000629	0.00544	CcSEcCtD
Linezolid—Pancreatitis—Acamprosate—alcohol dependence	0.000626	0.00541	CcSEcCtD
Linezolid—MAOA—endocrine gland—alcohol dependence	0.00062	0.0167	CbGeAlD
Linezolid—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.000616	0.00533	CcSEcCtD
Linezolid—Vaginal inflammation—Citalopram—alcohol dependence	0.00061	0.00527	CcSEcCtD
Linezolid—MAOB—Biological oxidations—ADH1B—alcohol dependence	0.000607	0.00596	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—ADH1A—alcohol dependence	0.000601	0.0059	CbGpPWpGaD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000594	0.00583	CbGpPWpGaD
Linezolid—MAOA—testis—alcohol dependence	0.000591	0.0159	CbGeAlD
Linezolid—Sweating increased—Naltrexone—alcohol dependence	0.000588	0.00508	CcSEcCtD
Linezolid—Candida infection—Citalopram—alcohol dependence	0.000582	0.00503	CcSEcCtD
Linezolid—MAOA—nervous system—alcohol dependence	0.00058	0.0156	CbGeAlD
Linezolid—Fluid retention—Citalopram—alcohol dependence	0.000579	0.005	CcSEcCtD
Linezolid—Vaginal infection—Citalopram—alcohol dependence	0.000576	0.00498	CcSEcCtD
Linezolid—Hyperglycaemia—Acamprosate—alcohol dependence	0.000576	0.00498	CcSEcCtD
Linezolid—Neuropathy—Citalopram—alcohol dependence	0.000572	0.00495	CcSEcCtD
Linezolid—Pneumonia—Acamprosate—alcohol dependence	0.000572	0.00495	CcSEcCtD
Linezolid—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.000561	0.00485	CcSEcCtD
Linezolid—MAOA—liver—alcohol dependence	0.000559	0.015	CbGeAlD
Linezolid—MAOA—central nervous system—alcohol dependence	0.000558	0.015	CbGeAlD
Linezolid—Stomatitis—Acamprosate—alcohol dependence	0.000555	0.00479	CcSEcCtD
Linezolid—Urine output increased—Citalopram—alcohol dependence	0.000551	0.00477	CcSEcCtD
Linezolid—Ecchymosis—Citalopram—alcohol dependence	0.000551	0.00477	CcSEcCtD
Linezolid—MAOA—cerebellum—alcohol dependence	0.000546	0.0147	CbGeAlD
Linezolid—Pneumonia—Naltrexone—alcohol dependence	0.000541	0.00468	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—KCNJ6—alcohol dependence	0.000532	0.00523	CbGpPWpGaD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000529	0.0052	CbGpPWpGaD
Linezolid—Sepsis—Citalopram—alcohol dependence	0.000529	0.00457	CcSEcCtD
Linezolid—Asthenia—Disulfiram—alcohol dependence	0.000529	0.00457	CcSEcCtD
Linezolid—MAOB—brain—alcohol dependence	0.000519	0.014	CbGeAlD
Linezolid—Phlebitis—Citalopram—alcohol dependence	0.000514	0.00444	CcSEcCtD
Linezolid—Haemoglobin—Acamprosate—alcohol dependence	0.000513	0.00444	CcSEcCtD
Linezolid—MAOA—Biological oxidations—ADH4—alcohol dependence	0.000511	0.00501	CbGpPWpGaD
Linezolid—Haemorrhage—Acamprosate—alcohol dependence	0.000511	0.00442	CcSEcCtD
Linezolid—Hypoaesthesia—Acamprosate—alcohol dependence	0.000508	0.00439	CcSEcCtD
Linezolid—Pharyngitis—Acamprosate—alcohol dependence	0.000507	0.00438	CcSEcCtD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000505	0.00496	CbGpPWpGaD
Linezolid—Polyuria—Citalopram—alcohol dependence	0.000504	0.00436	CcSEcCtD
Linezolid—Disorientation—Citalopram—alcohol dependence	0.000495	0.00428	CcSEcCtD
Linezolid—Dizziness—Disulfiram—alcohol dependence	0.000487	0.00421	CcSEcCtD
Linezolid—Injury—Citalopram—alcohol dependence	0.000482	0.00416	CcSEcCtD
Linezolid—Pharyngitis—Naltrexone—alcohol dependence	0.00048	0.00415	CcSEcCtD
Linezolid—Tinnitus—Acamprosate—alcohol dependence	0.000476	0.00412	CcSEcCtD
Linezolid—Thirst—Citalopram—alcohol dependence	0.000465	0.00402	CcSEcCtD
Linezolid—Rash—Disulfiram—alcohol dependence	0.000464	0.00402	CcSEcCtD
Linezolid—Headache—Disulfiram—alcohol dependence	0.000461	0.00399	CcSEcCtD
Linezolid—Chills—Acamprosate—alcohol dependence	0.000458	0.00396	CcSEcCtD
Linezolid—Hypoglycaemia—Citalopram—alcohol dependence	0.000454	0.00392	CcSEcCtD
Linezolid—Tinnitus—Naltrexone—alcohol dependence	0.000451	0.0039	CcSEcCtD
Linezolid—Hyponatraemia—Citalopram—alcohol dependence	0.000444	0.00384	CcSEcCtD
Linezolid—MAOA—brain—alcohol dependence	0.000443	0.0119	CbGeAlD
Linezolid—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.000443	0.00383	CcSEcCtD
Linezolid—Flatulence—Acamprosate—alcohol dependence	0.000438	0.00379	CcSEcCtD
Linezolid—Dysgeusia—Acamprosate—alcohol dependence	0.000435	0.00376	CcSEcCtD
Linezolid—MAOA—Biological oxidations—ADH7—alcohol dependence	0.000434	0.00426	CbGpPWpGaD
Linezolid—Chills—Naltrexone—alcohol dependence	0.000434	0.00375	CcSEcCtD
Linezolid—MAOB—Biological oxidations—ALDH2—alcohol dependence	0.000428	0.0042	CbGpPWpGaD
Linezolid—Muscle spasms—Acamprosate—alcohol dependence	0.000427	0.0037	CcSEcCtD
Linezolid—MAOA—Biological oxidations—GGT2—alcohol dependence	0.000416	0.00409	CbGpPWpGaD
Linezolid—Flatulence—Naltrexone—alcohol dependence	0.000415	0.00358	CcSEcCtD
Linezolid—Dysgeusia—Naltrexone—alcohol dependence	0.000412	0.00356	CcSEcCtD
Linezolid—Anaemia—Acamprosate—alcohol dependence	0.000411	0.00355	CcSEcCtD
Linezolid—Liver function test abnormal—Citalopram—alcohol dependence	0.000409	0.00353	CcSEcCtD
Linezolid—MAOA—Neuronal System—KCNJ6—alcohol dependence	0.000408	0.004	CbGpPWpGaD
Linezolid—Angioedema—Acamprosate—alcohol dependence	0.000406	0.00351	CcSEcCtD
Linezolid—Muscle spasms—Naltrexone—alcohol dependence	0.000404	0.0035	CcSEcCtD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000404	0.00396	CbGpPWpGaD
Linezolid—Hypokalaemia—Citalopram—alcohol dependence	0.000403	0.00348	CcSEcCtD
Linezolid—Vertigo—Acamprosate—alcohol dependence	0.000399	0.00345	CcSEcCtD
Linezolid—Cramp muscle—Citalopram—alcohol dependence	0.000399	0.00345	CcSEcCtD
Linezolid—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.000399	0.00345	CcSEcCtD
Linezolid—Leukopenia—Acamprosate—alcohol dependence	0.000398	0.00344	CcSEcCtD
Linezolid—Vision blurred—Naltrexone—alcohol dependence	0.000396	0.00343	CcSEcCtD
Linezolid—Gastritis—Citalopram—alcohol dependence	0.000392	0.00339	CcSEcCtD
Linezolid—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.00039	0.00337	CcSEcCtD
Linezolid—Cough—Acamprosate—alcohol dependence	0.000388	0.00335	CcSEcCtD
Linezolid—Convulsion—Acamprosate—alcohol dependence	0.000385	0.00333	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—GABRB1—alcohol dependence	0.000385	0.00378	CbGpPWpGaD
Linezolid—Angioedema—Naltrexone—alcohol dependence	0.000384	0.00332	CcSEcCtD
Linezolid—Hypertension—Acamprosate—alcohol dependence	0.000384	0.00332	CcSEcCtD
Linezolid—MAOA—Biological oxidations—ADH1B—alcohol dependence	0.000381	0.00374	CbGpPWpGaD
Linezolid—Eosinophilia—Citalopram—alcohol dependence	0.000379	0.00327	CcSEcCtD
Linezolid—Pancreatitis—Citalopram—alcohol dependence	0.000375	0.00324	CcSEcCtD
Linezolid—Sweating increased—Citalopram—alcohol dependence	0.000373	0.00322	CcSEcCtD
Linezolid—Dry mouth—Acamprosate—alcohol dependence	0.00037	0.0032	CcSEcCtD
Linezolid—Cough—Naltrexone—alcohol dependence	0.000367	0.00317	CcSEcCtD
Linezolid—Convulsion—Naltrexone—alcohol dependence	0.000364	0.00315	CcSEcCtD
Linezolid—Pancytopenia—Citalopram—alcohol dependence	0.000363	0.00314	CcSEcCtD
Linezolid—Hypertension—Naltrexone—alcohol dependence	0.000363	0.00314	CcSEcCtD
Linezolid—Anaphylactic shock—Acamprosate—alcohol dependence	0.000363	0.00314	CcSEcCtD
Linezolid—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000356	0.00307	CcSEcCtD
Linezolid—Thrombocytopenia—Acamprosate—alcohol dependence	0.000355	0.00307	CcSEcCtD
Linezolid—Skin disorder—Acamprosate—alcohol dependence	0.000352	0.00305	CcSEcCtD
Linezolid—Hyperhidrosis—Acamprosate—alcohol dependence	0.000351	0.00303	CcSEcCtD
Linezolid—Dry mouth—Naltrexone—alcohol dependence	0.00035	0.00303	CcSEcCtD
Linezolid—Anorexia—Acamprosate—alcohol dependence	0.000346	0.00299	CcSEcCtD
Linezolid—Hyperglycaemia—Citalopram—alcohol dependence	0.000345	0.00298	CcSEcCtD
Linezolid—MAOB—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000345	0.00338	CbGpPWpGaD
Linezolid—Anaphylactic shock—Naltrexone—alcohol dependence	0.000343	0.00297	CcSEcCtD
Linezolid—Pneumonia—Citalopram—alcohol dependence	0.000343	0.00297	CcSEcCtD
Linezolid—MAOB—Biological oxidations—CYP2E1—alcohol dependence	0.000342	0.00336	CbGpPWpGaD
Linezolid—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000338	0.00292	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.000335	0.00328	CbGpPWpGaD
Linezolid—Neuropathy peripheral—Citalopram—alcohol dependence	0.000334	0.00289	CcSEcCtD
Linezolid—Skin disorder—Naltrexone—alcohol dependence	0.000333	0.00288	CcSEcCtD
Linezolid—Stomatitis—Citalopram—alcohol dependence	0.000332	0.00287	CcSEcCtD
Linezolid—Hyperhidrosis—Naltrexone—alcohol dependence	0.000332	0.00287	CcSEcCtD
Linezolid—Insomnia—Acamprosate—alcohol dependence	0.000328	0.00284	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—GABRA2—alcohol dependence	0.000327	0.00321	CbGpPWpGaD
Linezolid—Anorexia—Naltrexone—alcohol dependence	0.000327	0.00283	CcSEcCtD
Linezolid—Paraesthesia—Acamprosate—alcohol dependence	0.000326	0.00282	CcSEcCtD
Linezolid—Dyspnoea—Acamprosate—alcohol dependence	0.000324	0.0028	CcSEcCtD
Linezolid—Somnolence—Acamprosate—alcohol dependence	0.000323	0.00279	CcSEcCtD
Linezolid—Dyspepsia—Acamprosate—alcohol dependence	0.000319	0.00276	CcSEcCtD
Linezolid—MAOA—Biological oxidations—MAOB—alcohol dependence	0.000316	0.0031	CbGpPWpGaD
Linezolid—Decreased appetite—Acamprosate—alcohol dependence	0.000315	0.00273	CcSEcCtD
Linezolid—MAOB—Biological oxidations—GGT1—alcohol dependence	0.000314	0.00308	CbGpPWpGaD
Linezolid—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000313	0.00271	CcSEcCtD
Linezolid—Insomnia—Naltrexone—alcohol dependence	0.000311	0.00268	CcSEcCtD
Linezolid—Pain—Acamprosate—alcohol dependence	0.00031	0.00268	CcSEcCtD
Linezolid—Constipation—Acamprosate—alcohol dependence	0.00031	0.00268	CcSEcCtD
Linezolid—Paraesthesia—Naltrexone—alcohol dependence	0.000308	0.00267	CcSEcCtD
Linezolid—Haemoglobin—Citalopram—alcohol dependence	0.000308	0.00266	CcSEcCtD
Linezolid—Haemorrhage—Citalopram—alcohol dependence	0.000306	0.00265	CcSEcCtD
Linezolid—Dyspnoea—Naltrexone—alcohol dependence	0.000306	0.00265	CcSEcCtD
Linezolid—Somnolence—Naltrexone—alcohol dependence	0.000305	0.00264	CcSEcCtD
Linezolid—Hypoaesthesia—Citalopram—alcohol dependence	0.000305	0.00263	CcSEcCtD
Linezolid—Pharyngitis—Citalopram—alcohol dependence	0.000304	0.00263	CcSEcCtD
Linezolid—Decreased appetite—Naltrexone—alcohol dependence	0.000298	0.00258	CcSEcCtD
Linezolid—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000297	0.00257	CcSEcCtD
Linezolid—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000296	0.00256	CcSEcCtD
Linezolid—Fatigue—Naltrexone—alcohol dependence	0.000296	0.00256	CcSEcCtD
Linezolid—MAOA—Neuronal System—GABRB1—alcohol dependence	0.000295	0.0029	CbGpPWpGaD
Linezolid—Pain—Naltrexone—alcohol dependence	0.000294	0.00254	CcSEcCtD
Linezolid—Constipation—Naltrexone—alcohol dependence	0.000294	0.00254	CcSEcCtD
Linezolid—Erythema multiforme—Citalopram—alcohol dependence	0.000289	0.0025	CcSEcCtD
Linezolid—Urticaria—Acamprosate—alcohol dependence	0.000288	0.00249	CcSEcCtD
Linezolid—Abdominal pain—Acamprosate—alcohol dependence	0.000287	0.00248	CcSEcCtD
Linezolid—Body temperature increased—Acamprosate—alcohol dependence	0.000287	0.00248	CcSEcCtD
Linezolid—Tinnitus—Citalopram—alcohol dependence	0.000285	0.00247	CcSEcCtD
Linezolid—MAOB—Biological oxidations—MAOA—alcohol dependence	0.000281	0.00276	CbGpPWpGaD
Linezolid—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000281	0.00243	CcSEcCtD
Linezolid—Chills—Citalopram—alcohol dependence	0.000275	0.00238	CcSEcCtD
Linezolid—Urticaria—Naltrexone—alcohol dependence	0.000273	0.00236	CcSEcCtD
Linezolid—Body temperature increased—Naltrexone—alcohol dependence	0.000271	0.00235	CcSEcCtD
Linezolid—Abdominal pain—Naltrexone—alcohol dependence	0.000271	0.00235	CcSEcCtD
Linezolid—MAOA—Biological oxidations—ALDH2—alcohol dependence	0.000268	0.00263	CbGpPWpGaD
Linezolid—Erythema—Citalopram—alcohol dependence	0.000267	0.0023	CcSEcCtD
Linezolid—Flatulence—Citalopram—alcohol dependence	0.000263	0.00227	CcSEcCtD
Linezolid—Dysgeusia—Citalopram—alcohol dependence	0.000261	0.00226	CcSEcCtD
Linezolid—Asthenia—Acamprosate—alcohol dependence	0.00026	0.00225	CcSEcCtD
Linezolid—Pruritus—Acamprosate—alcohol dependence	0.000257	0.00222	CcSEcCtD
Linezolid—Muscle spasms—Citalopram—alcohol dependence	0.000256	0.00222	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.000254	0.00249	CbGpPWpGaD
Linezolid—Vision blurred—Citalopram—alcohol dependence	0.000251	0.00217	CcSEcCtD
Linezolid—MAOA—Neuronal System—GABRA2—alcohol dependence	0.000251	0.00246	CbGpPWpGaD
Linezolid—Diarrhoea—Acamprosate—alcohol dependence	0.000248	0.00215	CcSEcCtD
Linezolid—Anaemia—Citalopram—alcohol dependence	0.000246	0.00213	CcSEcCtD
Linezolid—Asthenia—Naltrexone—alcohol dependence	0.000246	0.00213	CcSEcCtD
Linezolid—Angioedema—Citalopram—alcohol dependence	0.000244	0.00211	CcSEcCtD
Linezolid—Pruritus—Naltrexone—alcohol dependence	0.000243	0.0021	CcSEcCtD
Linezolid—Dizziness—Acamprosate—alcohol dependence	0.00024	0.00207	CcSEcCtD
Linezolid—Vertigo—Citalopram—alcohol dependence	0.000239	0.00207	CcSEcCtD
Linezolid—Leukopenia—Citalopram—alcohol dependence	0.000239	0.00206	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—ALDH2—alcohol dependence	0.000238	0.00233	CbGpPWpGaD
Linezolid—Diarrhoea—Naltrexone—alcohol dependence	0.000235	0.00203	CcSEcCtD
Linezolid—Cough—Citalopram—alcohol dependence	0.000233	0.00201	CcSEcCtD
Linezolid—Convulsion—Citalopram—alcohol dependence	0.000231	0.002	CcSEcCtD
Linezolid—Vomiting—Acamprosate—alcohol dependence	0.000231	0.00199	CcSEcCtD
Linezolid—Hypertension—Citalopram—alcohol dependence	0.00023	0.00199	CcSEcCtD
Linezolid—Rash—Acamprosate—alcohol dependence	0.000229	0.00198	CcSEcCtD
Linezolid—Dermatitis—Acamprosate—alcohol dependence	0.000229	0.00198	CcSEcCtD
Linezolid—Headache—Acamprosate—alcohol dependence	0.000227	0.00197	CcSEcCtD
Linezolid—Dizziness—Naltrexone—alcohol dependence	0.000227	0.00196	CcSEcCtD
Linezolid—Dry mouth—Citalopram—alcohol dependence	0.000222	0.00192	CcSEcCtD
Linezolid—Vomiting—Naltrexone—alcohol dependence	0.000218	0.00189	CcSEcCtD
Linezolid—Anaphylactic shock—Citalopram—alcohol dependence	0.000218	0.00188	CcSEcCtD
Linezolid—Rash—Naltrexone—alcohol dependence	0.000216	0.00187	CcSEcCtD
Linezolid—MAOA—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000216	0.00212	CbGpPWpGaD
Linezolid—Dermatitis—Naltrexone—alcohol dependence	0.000216	0.00187	CcSEcCtD
Linezolid—Nausea—Acamprosate—alcohol dependence	0.000216	0.00186	CcSEcCtD
Linezolid—Headache—Naltrexone—alcohol dependence	0.000215	0.00186	CcSEcCtD
Linezolid—MAOA—Biological oxidations—CYP2E1—alcohol dependence	0.000214	0.00211	CbGpPWpGaD
Linezolid—Thrombocytopenia—Citalopram—alcohol dependence	0.000213	0.00184	CcSEcCtD
Linezolid—Skin disorder—Citalopram—alcohol dependence	0.000211	0.00183	CcSEcCtD
Linezolid—Hyperhidrosis—Citalopram—alcohol dependence	0.00021	0.00182	CcSEcCtD
Linezolid—Anorexia—Citalopram—alcohol dependence	0.000207	0.00179	CcSEcCtD
Linezolid—Nausea—Naltrexone—alcohol dependence	0.000204	0.00176	CcSEcCtD
Linezolid—MAOB—Metabolism—ADH6—alcohol dependence	0.000198	0.00194	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—GGT1—alcohol dependence	0.000197	0.00193	CbGpPWpGaD
Linezolid—Insomnia—Citalopram—alcohol dependence	0.000197	0.0017	CcSEcCtD
Linezolid—Paraesthesia—Citalopram—alcohol dependence	0.000195	0.00169	CcSEcCtD
Linezolid—Dyspnoea—Citalopram—alcohol dependence	0.000194	0.00168	CcSEcCtD
Linezolid—Somnolence—Citalopram—alcohol dependence	0.000193	0.00167	CcSEcCtD
Linezolid—Dyspepsia—Citalopram—alcohol dependence	0.000191	0.00166	CcSEcCtD
Linezolid—Decreased appetite—Citalopram—alcohol dependence	0.000189	0.00163	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—GRIN2B—alcohol dependence	0.000188	0.00185	CbGpPWpGaD
Linezolid—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000188	0.00162	CcSEcCtD
Linezolid—Fatigue—Citalopram—alcohol dependence	0.000188	0.00162	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000187	0.00184	CbGpPWpGaD
Linezolid—Constipation—Citalopram—alcohol dependence	0.000186	0.00161	CcSEcCtD
Linezolid—Pain—Citalopram—alcohol dependence	0.000186	0.00161	CcSEcCtD
Linezolid—MAOA—Transmission across Chemical Synapses—SLC6A3—alcohol dependence	0.000185	0.00182	CbGpPWpGaD
Linezolid—MAOB—Biological oxidations—POMC—alcohol dependence	0.000183	0.0018	CbGpPWpGaD
Linezolid—MAOA—Neuronal System—ALDH2—alcohol dependence	0.000182	0.00179	CbGpPWpGaD
Linezolid—Gastrointestinal pain—Citalopram—alcohol dependence	0.000178	0.00154	CcSEcCtD
Linezolid—Urticaria—Citalopram—alcohol dependence	0.000173	0.00149	CcSEcCtD
Linezolid—Body temperature increased—Citalopram—alcohol dependence	0.000172	0.00149	CcSEcCtD
Linezolid—Abdominal pain—Citalopram—alcohol dependence	0.000172	0.00149	CcSEcCtD
Linezolid—MAOB—Metabolism—ADH1A—alcohol dependence	0.000164	0.00161	CbGpPWpGaD
Linezolid—Asthenia—Citalopram—alcohol dependence	0.000156	0.00135	CcSEcCtD
Linezolid—MAOA—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.000156	0.00153	CbGpPWpGaD
Linezolid—Pruritus—Citalopram—alcohol dependence	0.000154	0.00133	CcSEcCtD
Linezolid—Diarrhoea—Citalopram—alcohol dependence	0.000149	0.00129	CcSEcCtD
Linezolid—MAOA—Neuronal System—GRIN2B—alcohol dependence	0.000144	0.00141	CbGpPWpGaD
Linezolid—Dizziness—Citalopram—alcohol dependence	0.000144	0.00124	CcSEcCtD
Linezolid—MAOA—Neuronal System—SLC6A3—alcohol dependence	0.000142	0.00139	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ADH4—alcohol dependence	0.000139	0.00137	CbGpPWpGaD
Linezolid—Vomiting—Citalopram—alcohol dependence	0.000138	0.0012	CcSEcCtD
Linezolid—Rash—Citalopram—alcohol dependence	0.000137	0.00119	CcSEcCtD
Linezolid—Dermatitis—Citalopram—alcohol dependence	0.000137	0.00118	CcSEcCtD
Linezolid—Headache—Citalopram—alcohol dependence	0.000136	0.00118	CcSEcCtD
Linezolid—Nausea—Citalopram—alcohol dependence	0.000129	0.00112	CcSEcCtD
Linezolid—MAOA—Metabolism—ADH6—alcohol dependence	0.000124	0.00122	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ADH7—alcohol dependence	0.000118	0.00116	CbGpPWpGaD
Linezolid—MAOA—Biological oxidations—POMC—alcohol dependence	0.000115	0.00113	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GGT2—alcohol dependence	0.000113	0.00111	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ADH1B—alcohol dependence	0.000104	0.00102	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ADH1A—alcohol dependence	0.000103	0.00101	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ADH4—alcohol dependence	8.73e-05	0.000857	CbGpPWpGaD
Linezolid—MAOA—SIDS Susceptibility Pathways—EP300—alcohol dependence	8.24e-05	0.000809	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ADH7—alcohol dependence	7.43e-05	0.000729	CbGpPWpGaD
Linezolid—MAOB—Metabolism—ALDH2—alcohol dependence	7.31e-05	0.000718	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GGT2—alcohol dependence	7.12e-05	0.000699	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ADH1B—alcohol dependence	6.51e-05	0.000639	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GOT2—alcohol dependence	6.22e-05	0.00061	CbGpPWpGaD
Linezolid—MAOB—Metabolism—CYP2E1—alcohol dependence	5.85e-05	0.000574	CbGpPWpGaD
Linezolid—MAOA—Metabolism—MAOB—alcohol dependence	5.4e-05	0.00053	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GGT1—alcohol dependence	5.37e-05	0.000527	CbGpPWpGaD
Linezolid—MAOB—Metabolism—GOT1—alcohol dependence	5.37e-05	0.000527	CbGpPWpGaD
Linezolid—MAOB—Metabolism—MAOA—alcohol dependence	4.81e-05	0.000472	CbGpPWpGaD
Linezolid—MAOA—Metabolism—ALDH2—alcohol dependence	4.59e-05	0.00045	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GOT2—alcohol dependence	3.9e-05	0.000383	CbGpPWpGaD
Linezolid—MAOA—Metabolism—CYP2E1—alcohol dependence	3.67e-05	0.00036	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GGT1—alcohol dependence	3.37e-05	0.000331	CbGpPWpGaD
Linezolid—MAOA—Metabolism—GOT1—alcohol dependence	3.37e-05	0.000331	CbGpPWpGaD
Linezolid—MAOB—Metabolism—POMC—alcohol dependence	3.13e-05	0.000307	CbGpPWpGaD
Linezolid—MAOB—Metabolism—EP300—alcohol dependence	2.08e-05	0.000204	CbGpPWpGaD
Linezolid—MAOA—Metabolism—POMC—alcohol dependence	1.96e-05	0.000193	CbGpPWpGaD
Linezolid—MAOA—Metabolism—EP300—alcohol dependence	1.3e-05	0.000128	CbGpPWpGaD
